Vanda Pharmaceuticals' Fanapt (iloperidone) receives FDA approval for bipolar I disorder treatment.

Vanda Pharmaceuticals' Fanapt (iloperidone) tablets receive FDA approval for treating manic or mixed episodes associated with bipolar I disorder in adults. The drug, initially approved for treating schizophrenia in 2009, demonstrated significant improvement compared to placebo in a pivotal study involving around 400 patients. This expansion of Fanapt's application increases its commercial opportunity.